J 2023

Cold atmospheric plasma-enabled platelet vesicle incorporated iron oxide nano-propellers for thrombolysis

JHENG, Pei-Ru, Chia-Che CHIANG, Jiunn-Horng KANG, Yu-Jui FAN, Kevin C. -W. WU et. al.

Basic information

Original name

Cold atmospheric plasma-enabled platelet vesicle incorporated iron oxide nano-propellers for thrombolysis

Authors

JHENG, Pei-Ru, Chia-Che CHIANG, Jiunn-Horng KANG, Yu-Jui FAN, Kevin C. -W. WU, Yan-Ting CHEN, Jia-Wei LIANG, Nima BOLOUKI (364 Islamic Republic of Iran, belonging to the institution), Jyh-Wei LEE, Jang-Hsing HSIEH and Er-Yuan CHUANG

Edition

Materials Today Bio, Elsevier, 2023, 2590-0064

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10305 Fluids and plasma physics

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 8.200 in 2022

RIV identification code

RIV/00216224:14310/23:00133048

Organization unit

Faculty of Science

UT WoS

001128488200001

Keywords in English

Cold atmospheric plasma; Iron oxide; Platelet vesicle; Phototherapy; Magnetotherapy; Thrombolysis

Tags

Tags

International impact, Reviewed
Změněno: 21/2/2024 15:28, Mgr. Marie Šípková, DiS.

Abstract

V originále

A new approach to treating vascular blockages has been developed to overcome the limitations of current thrombolytic therapies. This approach involves biosafety and multimodal plasma-derived theranostic platelet vesicle incorporating iron oxide constructed nano-propellers platformed technology that possesses fluorescent and magnetic features and manifold thrombus targeting modes. The platform is capable of being guided and visualized remotely to specifically target thrombi, and it can be activated using near-infrared phototherapy along with an actuated magnet for magnetotherapy. In a murine model of thrombus lesion, this proposed multimodal approach showed an approximately 80% reduction in thrombus residues. Moreover, the new strategy not only improves thrombolysis but also boosts the rate of lysis, making it a promising candidate for time-sensitive thrombolytic therapy.

Links

90097, large research infrastructures
Name: CEPLANT